Lilly Obesity Drug Success Drives Record Rally and Wall Street Optimism
Lilly's obesity drug success is cited as a driver of a record rally and optimism on Wall Street.
Related stories
Alliant Energy Reports Third-Quarter Revenue of $1.29 Billion
M impact | EQUITY | Oct 29, 2026, 10:01 PM UTC
Alliant Energy Reports Q3 Pretax Profit of $331 Million
M impact | EQUITY | Oct 29, 2026, 10:01 PM UTC
Braskem Publishes Third-Quarter 2026 Production and Sales Report
Braskem published its third-quarter 2026 production and sales report.
M impact | EQUITY | Oct 29, 2026, 10:01 PM UTC
US session market picture: S&P 500 -0.94%, Nasdaq 100 -2.54%; EUR/USD +0.22%, WTI +0.08%, WBD leads volume
US session market picture. US index futures: S and P futures is down 0.94 percent, Nasdaq futures is down 2.54 percent, Dow futures is down 0.35 percent and Russell futures is up 1
M impact | EQUITY | Oct 29, 2026, 10:00 PM UTC
Twilio Forecasts Slower Q4 Organic Growth Despite Q3 Results Beat
M impact | EQUITY | Oct 29, 2026, 09:55 PM UTC
Amazon Q3 Profit Falls, Stock Down 6%
Amazon reported third-quarter net income of $20.69 billion, or $1.89 per share, compared with $21… a year earlier. Net sales increased 12%; the profit decline reflected the absence
H impact | EQUITY | Oct 29, 2026, 09:52 PM UTC